Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

This publication has 67 references indexed in Scilit:

• A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer
  European Journal Of Cancer, 1996
• Tyrosine kinase inhibitor as a novel signal transduction and antiproliferative agent: prostate cancer
  Molecular and Cellular Endocrinology, 1996
• Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research
  Breast Cancer Research and Treatment, 1995
• The type 1 (EGFR-related) family of growth factor receptors and their ligands
  Progress in Growth Factor Research, 1992
• Interaction of Heparin-Binding EGF-Like Growth Factor (HB-EGF) with the Epidermal Growth Factor Receptor: Modulation by Heparin, Heparinase, or Synthetic Heparin-Binding HB-EGF Fragments
  Growth Factors, 1992
• Deletion-mutant epidermal growth factor receptor in human gliomas: Effect of type II mutation on receptor function
  Biochemical and Biophysical Research Communications, 1991
• Binding of SH2 Domains of Phospholipase Cγ1, GAP, and Src to Activated Growth Factor Receptors
  Science, 1990
• Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor
  Biochemistry, 1987
• Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro
  Cell, 1985
• Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin
  Nature, 1985